VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2022 | Radioimmunoconjugates in the age of modern immuno-oncology

Prashanth Ashok Kumar • 7 Dec 2022
SABCS 2022
Breast Cancer
Immuno-Oncology Radiotherapy

Prashanth Ashok Kumar, MD, Upstate University Hospital, Syracuse, NY, talks on radioimmunoconjugates in the age of modern immuno-oncology. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Prashanth Ashok Kumar

2:12
The impact of adjuvant chemo on OS in HR+ and node+ BC with an Oncotype Dx score of 25 or less
Prashanth Ashok Kumar • 7 Dec 2022
0:38
The role of the Oncotype DX assay in the management of patients with breast cancer
Prashanth Ashok Kumar • 7 Dec 2022
1:15
Remaining questions regarding the use of adjuvant chemotherapy in breast cancer
Prashanth Ashok Kumar • 7 Dec 2022
0:55
Key highlights from SABCS 2022
Prashanth Ashok Kumar • 7 Dec 2022

Related Videos

2:52
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
Peter Schmid
1:52
What impact will biosimilars have on clinical life?
Diana Lüftner
1:22
Drug shortages around the world: why communication is key
Fatima Cardoso
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals